A Revolutionary Way to Treat Hair Loss and Thinning Contain: 1 x ÉVOLIS SHAMPOO FOR MEN 300ML 2 x EVOLIS TONIC FOR MEN 50ML The évolis® active pack provides up to three months supply of tonic, packaged with a free bottle of unique 3-in1 shampoo with catch and release polymer technology. évolis® tonic is the first an only product harnessing the power of FGF5 blocking ingredients to prevent hair fall, and increase hair growth. FGF5 is the key villain in the hair cycle and has been identified as a key component of pattern hair loss by multiple independent large-scale genetic studies. By harnessing natural FGF5 blocking actives, évolis® restores and extends the growth phase of the hair cycle, can stop hair falling out and keeps hair growing longer, stronger and faster. évolis® has been clinically tested to help reduce hair loss and increase the number of growing hair follicles. In a controlled study, évolis® users reduced hair loss by 82% and increased hair growth by 44% over 4 months*. Each évolis® tonic is made in Australia to pharmaceutical standards to ensure the highest quality of each product. The évolis® 3 in 1 shampoo is the perfect companion for use with évolis® tonic évolis® shampoo is formulated with advanced three in one technology to enhance hair shine and strength, while improving scalp health and hair vitality. The unique Catch & Release Polymer (CRP) delivers actives and nourishment directly to the hair shaft, providing instant volume boost. 3 in 1 technology -how does it work? ShampoosCleanses the scalp and hair, removing impurities and sebum from the follicular pores and scalp, improving scalp health and hair vitality. Prepares the scalp for maximum tonic penetration. ConditionsRestores manageability to hair, providing strength and elasticity. Hair is left touchable and soft, without being weighed down VolumisesThe unique CRP wraps around the hair shaft, attracting moisture and locking in the actives, providing volume, nourishment, condition and shine. *Blinded, placebo-controlled, study of men and women over 16 weeks (Burg et al., 2017).